A new trading day began on Friday, with Health Catalyst Inc (NASDAQ: HCAT) stock price up 16.26% from the previous day of trading, before settling in for the closing price of $2.03. HCAT’s price has ranged from $2.02 to $9.24 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 38.24%. Meanwhile, its annual earnings per share averaged -26.82%. With a float of $65.96 million, this company’s outstanding shares have now reached $70.62 million.
Health Catalyst Inc (HCAT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Health Information Services Industry. The insider ownership of Health Catalyst Inc is 6.24%, while institutional ownership is 78.28%. The most recent insider transaction that took place on Sep 05 ’25, was worth 20,705. In this transaction General Counsel of this company sold 6,175 shares at a rate of $3.35, taking the stock ownership to the 141,812 shares. Before that another transaction happened on Sep 05 ’25, when Company’s Officer proposed sale 6,175 for $3.30, making the entire transaction worth $20,378.
Health Catalyst Inc (HCAT) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.04 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -26.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.30% during the next five years compared to 38.24% growth over the previous five years of trading.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
Here are Health Catalyst Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.86. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.58, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.35 in one year’s time.
Technical Analysis of Health Catalyst Inc (HCAT)
Looking closely at Health Catalyst Inc (NASDAQ: HCAT), its last 5-days average volume was 0.71 million, which is a jump from its year-to-date volume of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 9.96%.
During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 16.35%, which indicates a significant decrease from 25.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.24 in the past 14 days, which was higher than the 0.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.86, while its 200-day Moving Average is $3.71. However, in the short run, Health Catalyst Inc’s stock first resistance to watch stands at $2.50. Second resistance stands at $2.64. The third major resistance level sits at $2.88. If the price goes on to break the first support level at $2.13, it is likely to go to the next support level at $1.89. Should the price break the second support level, the third support level stands at $1.75.
Health Catalyst Inc (NASDAQ: HCAT) Key Stats
With a market capitalization of 166.92 million, the company has a total of 70,731K Shares Outstanding. Currently, annual sales are 306,580 K while annual income is -69,500 K. The company’s previous quarter sales were 76,320 K while its latest quarter income was -22,230 K.
